SpectraScience Inc (SCIE) - Product Pipeline Analysis, 2018 Update
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
SpectraScience Inc Company Overview 5
SpectraScience Inc Company Snapshot 5
SpectraScience Inc Pipeline Products and Ongoing Clinical Trials Overview 5
SpectraScience Inc – Pipeline Analysis Overview 8
Business Description 8
SpectraScience Inc - Key Facts 8
SpectraScience Inc - Major Products and Services 9
SpectraScience Inc Pipeline Products by Development Stage 10
SpectraScience Inc Ongoing Clinical Trials by Trial Status 12
SpectraScience Inc Pipeline Products Overview 14
a/LCI System - Barrett's Esophagus 14
a/LCI System - Barrett's Esophagus Product Overview 14
Next Generation Multi-Modal Fluorescence And Broadband Spectroscopy System 15
Next Generation Multi-Modal Fluorescence And Broadband Spectroscopy System Product Overview 15
WavSTAT - Inflammatory Bowel Syndrome 16
WavSTAT - Inflammatory Bowel Syndrome Product Overview 16
WavSTAT - Lung Cancer 17
WavSTAT - Lung Cancer Product Overview 17
WavSTAT - Pancreatic Cancer 18
WavSTAT - Pancreatic Cancer Product Overview 18
WavSTAT 4 System - Colon Cancer 19
WavSTAT 4 System - Colon Cancer Product Overview 19
WavSTAT Optical Biopsy System - Esophageal Cancer 20
WavSTAT Optical Biopsy System - Esophageal Cancer Product Overview 20
WavSTAT4 Optical Biopsy System 21
WavSTAT4 Optical Biopsy System Product Overview 21
WavSTAT4 Optical Biopsy System Clinical Trial 22
SpectraScience Inc - Key Competitors 23
SpectraScience Inc - Key Employees 24
SpectraScience Inc - Key Employee Biographies 25
SpectraScience Inc - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
SpectraScience Inc, Recent Developments 27
Nov 01, 2016: SpectraScience Announces Presentation of WavSTAT4 Clinical Results for the Diagnosis of Small Colorectal Cancer Polyps at UEGW 27
Oct 04, 2016: SpectraScience Announces Presentation of WavSTAT4 Clinical Results for the Diagnosis of Small Colorectal Cancer Polyps at UEGW 27
Aug 23, 2016: SpectraScience Announces Accuracy of WavSTAT4 in the Diagnosis of Small Colorectal Cancer Polyps Confirmed 27
Jul 19, 2016: SpectraScience Appoints AMG as Exclusive Distributor in Middle East 28
May 24, 2016: SpectraScience Announces First Use of WavSTAT4 Optical Biopsy System in Spain 28
Apr 19, 2016: SpectraScience Study Published Confirming Accuracy of WavSTAT4 in the Diagnosis of Small Colorectal Cancer Polyps 28
Mar 29, 2016: SpectraScience Announces Second Shipment of WavSTAT4 Console to Leeds, England 29
Feb 02, 2016: SpectraScience Announces Publication of Clinical Data 29
Jan 19, 2016: SpectraScience to Display WavSTAT Optical Biopsy System at Arab Health Conference 29
Dec 08, 2015: SpectraScience Study Confirms Accuracy of WavSTAT4 in the Diagnosis of Small Colorectal Cancer Polyps 29
Appendix 31
Methodology 31
About GlobalData 34
Contact Us 34
Disclaimer 34
Summary
SpectraScience Inc (SpectraScience) is a medical device company, which undertakes the design, development, manufacture and marketing of light-based technology products. The company offers its proprietary WavSTAT Optical Biopsy System to diagnose tissue health optically by using light. This system is mainly used in diagnosing colorectal cancer and also plans to extend its application to esophageal, bladder, lung and other cancers. SpectraScience has developed two products, namely, the WavSTAT mobile console and optical biopsy forceps based on this technology. The company markets its WavSTAT System in the international markets through a distribution agreement with PENTAX Europe GmbH. SpectraScience is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company SpectraScience Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company